Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Glutamate receptor ionotropic, NMDA 3B (GRIN3B, also known as GluN3B or NR3B), is a subunit of the NMDA (N-methyl-D-aspartate) receptor, a type of ionotropic glutamate receptor that forms ligand-gated ion channels in the central nervous system. NMDA receptors are heterotetrameric complexes assembled from NR1, NR2 (A-D), and NR3 (A-B) subunits; GRIN3B encodes the GluN3B subunit. When incorporated, GluN3B changes the receptor’s electrophysiological properties—lowering calcium permeability and modifying channel activation and deactivation kinetics. GluN3B is expressed primarily in motor neurons and forms glycine-activated channels with GluN1 and glutamate-activated channels with GluN1 and GluN2. The NMDA receptor is critical for excitatory neurotransmission, synaptic plasticity, learning, and memory. Variants in GRIN3B have been associated with certain neurodevelopmental and neuropsychiatric disorders, though drugs specifically targeting this subunit are not currently available. NMDA receptor antagonists (like memantine and ketamine) act broadly on all NMDA receptor subunits
Channel blockade (voltage-dependent block by Mg2+ ions is reduced in GluN3B-containing NMDA receptors) - Inhibition of cation (Na+, K+, Ca2+) flux through the ion channel
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Glutamate receptor ionotropic, NMDA 3B (GRIN3B).